Vektor Medical
Enables non invasive 3D mapping of heart arrhythmias using standard 12 lead ECGs.
What they do
Develops clinical software that uses standard 12 lead ECG data to generate a 3D map of the heart, identifying arrhythmia sources. Electrophysiologists use this tool before or during ablation procedures to locate problematic tissue without invasive catheters.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Arrhythmia mapping
- Product type
- Software as a medical device
- Stage
- Series A
- Headquarters
- San Diego, United States
- Region
- North America
- Founded
- 2017
- Total funding
- $16M raised
Notable investors: Solas BioVentures, TVM Capital Life Science.